The Incidence of Hyponatraemia and Its Effect on the ECOG Performance Status among Lung Cancer Patients
Author:
Open Access
- 1 January 2013
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 7 (8) , 1678-82
Abstract
Hyponatraemia is one of the common electrolytic disorders which are associated with lung cancer. Hyponatraemia may influence the ECOG performance status at presentation. Also, to the best of our knowledge, we found only limited Indian studies where the ECOG score was correlated with the serum sodium status in lung cancer patients on presentation. To assess the incidence of hyponatraemia among the patients of carcinoma of the lung before putting them into the specific treatment category for cancer and to check the effects on their ECOG performance status. A cross-sectional, observational study was conducted on 116 consecutive patients of lung cancer during the period from November 2011 to October 2012. The patients with a histologically proven diagnosis of lung cancer were grouped initially according to their ECOG performance statuses. The serum sodium value of each patient was measured and the hyponatraemic patients were given treatment according to the protocol. The correlation of the ECOG performance status with the serum sodium of the lung cancer patients was measured. To check for any laboratory error in serum sodium, we selected (n = 58) age, sex and socioeconomic matched control patients. At presentation 44.8% of the lung cancer patients showed hyponatraemia [52/116]. The ECOG score was significantly poor in the advanced clinical stages (ECOG ≤2 Vs ECOG ≥ 3 in NSCLC cases, χ(2) =11.25, P=.0008). The ECOG performance status score at admission showed a negative correlation with the serum sodium status which was measured on admission among all the patients (Pearson correlation coefficient = - 0.186). The clinical stage of the lung cancer also showed a positive correlation with the ECOG score at admission in our study (Pearson correlation coefficient = 0.295). Hyponatraemia is not an uncommon condition and it should be suspected and screened in each patient, as it may influence the ECOG performance status score, which serves as an important factor in the prognosis of lung cancer.Keywords
This publication has 22 references indexed in Scilit:
- Hyponatremia as prognostic factor in small cell lung cancer – A retrospective single institution analysisRespiratory Medicine, 2012
- [Hyponatremia caused by pituitary metastasis of lung cancer].2011
- Tumor-Related HyponatremiaClinical Medicine & Research, 2007
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancerLung Cancer, 2006
- Performance status score: do patients and their oncologists agree?British Journal of Cancer, 2003
- Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancerCancer Chemotherapy and Pharmacology, 2000
- A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosisSupportive Care in Cancer, 2000
- Syndrome of inappropriate secretion of antidiuretic hormone in malignancySeminars in Oncology Nursing, 1999
- A Prospective Study of Patients with Lung Cancer and Hyponatremia of MalignancyAmerican Journal of Respiratory and Critical Care Medicine, 1997
- A Pilot Study of the Functional Living Index-Cancer (FLIC) Scale for the Assessment of Quality of Life for Metastatic Lung Cancer PatientsAmerican Journal of Clinical Oncology, 1988